✦ LIBER ✦

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

✍ Scribed by David R. Nelson; Yves Benhamou; Wan–Long Chuang; Eric J. Lawitz; Maribel Rodriguez–Torres; Robert Flisiak; Jens W.F. Rasenack; Wiesław Kryczka; Chuan–Mo Lee; Vincent G. Bain; Stephen Pianko; Keyur Patel; Patrick W. Cronin; Erik Pulkstenis; G. Mani Subramanian; John G. McHutchison

Book ID: 119761628
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 981 KB
Volume: 139
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2010.06.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

424 RESPIRATORY ALTERATIONS IN GENOTYPE

424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY

✍ G. Foster; R. Flisiak; W.-L. Chuang; J. George; J. Rasenack; A. Sood; P. Komolmi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Randomized trial comparing pegylated int

Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

✍ Montserrat Laguno; Carmen Cifuentes; Javier Murillas; Sergio Veloso; Maria Larro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

1042 EFFICACY AND SAFETY RESULTS OF ALBI

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Dose comparison study of pegylated inter

Dose comparison study of pegylated interferon-α-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: A randomized clinical trial

✍ Tomokazu Kawaoka; Yoshiiku Kawakami; Keiji Tsuji; Hiroyuki Ito; Mikiya Kitamoto; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

[572] RANDOMIZED, OPEN LABEL TRIAL COMPA

[572] RANDOMIZED, OPEN LABEL TRIAL COMPARING EFFICACY AND SAFETY OF PEGYLATED INTERFERON ALFA 2b VS ALFA 2b TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH NON 2/3 GENOTYPES - FINAL ANALYSIS

✍ H. Berak; A. Kolakowska-Rzadzka; M. Wasilewski; J. Kowalska; J.J. Stanczak; K. B 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi